JAC Advance Access published online on November 28, 2002
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkg023
© 2002 by The British Society for Antimicrobial Chemotherapy
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In Brief
1 Department of Clinical
Microbiology and Infection Control, Vrije Universiteit
Medical Centre, de Boelelaan 1117, 1081 HV Amsterdam, The Netherlands
* Corresponding author. E-mail: yj.debets{at}vumc.nl.
Received 24 June 2002
; revised 11 August 2002
; accepted 27 September 2002
In Ecuador, Helicobacter pylori infections
are highly prevalent. A total of 42 H. pylori clinical isolates
from 86 patients attending the outpatient clinic of the gastroenterology
department of the university hospital of Guayaquil in Ecuador were
characterized. Their susceptibility, and cagA and vacA status were determined. Resistance to metronidazole
and clarithromycin was found in 80.9% and 9.5% of
strains, respectively. Neither amoxicillin- nor tetracycline-resistant strains
were found. The most prevalent genotype was the cagA+, vacA s1b,m1 type. This genotype was associated
with gastric cancer and peptic ulcer. Typing by random amplified
polymorphic DNA showed no genetic relationship among the strains.
Keywords: Helicobacter pylori, Ecuador,
antibiotic resistance, typing, virulence factors
Characteristics of clinical Helicobacter pylori strains from Ecuador
2 Department of Molecular Biology, Universidad
Católica, Guayaquil, Ecuador
3 Department
of Gastroenterology, SOLCA Hospital, Guayaquil, Ecuador
4 Department of Gastroenterology, Vrije Universiteit
Medical Centre, de Boelelaan 1117, 1081 HV Amsterdam, The Netherlands
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. Alvarez, J. I. Moncayo, J. J. Santacruz, M. Santacoloma, L. F. Corredor, and E. Reinosa Antimicrobial Susceptibility and Mutations Involved in Clarithromycin Resistance in Helicobacter pylori Isolates from Patients in the Western Central Region of Colombia Antimicrob. Agents Chemother., September 1, 2009; 53(9): 4022 - 4024. [Abstract] [Full Text] [PDF] |
||||
